Catalyst Pharmaceuticals, Inc. (CPRX) shares rose 5.38 percent to $20.76 on Wednesday, gaining $1.06, after the company announced that its Board of Directors authorized a new share repurchase program to buy back up to $200 million of outstanding common stock between October 1, 2025, and December 31, 2026. The stock opened at $20.38 and traded between $20.13 and $22.02, compared with a previous close of $19.70 on the Nasdaq. Trading volume reached 2.96 million shares, above the average of 1.47 million. Catalyst now trades within a 52-week range of $19.05 to $26.58.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.